- Home
- SBFM vs AQMS Comparison
SBFM vs AQMS Comparison
Compare SBFM & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- AQMS
- Stock Information
- Founded
- SBFM 2006
- AQMS 2014
- Country
- SBFM United States
- AQMS United States
- Employees
- SBFM N/A
- AQMS N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- SBFM Health Care
- AQMS Industrials
- Exchange
- SBFM Nasdaq
- AQMS Nasdaq
- Market Cap
- SBFM 6.7M
- AQMS 5.5M
- IPO Year
- SBFM N/A
- AQMS 2015
- Fundamental
- Price
- SBFM $1.57
- AQMS $0.52
- Analyst Decision
- SBFM Strong Buy
- AQMS Strong Buy
- Analyst Count
- SBFM 1
- AQMS 3
- Target Price
- SBFM $15.00
- AQMS $21.00
- AVG Volume (30 Days)
- SBFM 196.4K
- AQMS 6.6M
- Earning Date
- SBFM 08-15-2025
- AQMS 08-04-2025
- Dividend Yield
- SBFM N/A
- AQMS N/A
- EPS Growth
- SBFM N/A
- AQMS N/A
- EPS
- SBFM N/A
- AQMS N/A
- Revenue
- SBFM $36,234,578.00
- AQMS N/A
- Revenue This Year
- SBFM $32.20
- AQMS N/A
- Revenue Next Year
- SBFM $32.74
- AQMS $550.00
- P/E Ratio
- SBFM N/A
- AQMS N/A
- Revenue Growth
- SBFM 35.51
- AQMS N/A
- 52 Week Low
- SBFM $1.17
- AQMS $0.47
- 52 Week High
- SBFM $6.19
- AQMS $6.60
- Technical
- Relative Strength Index (RSI)
- SBFM 53.18
- AQMS 39.81
- Support Level
- SBFM $1.51
- AQMS $0.53
- Resistance Level
- SBFM $1.61
- AQMS $0.65
- Average True Range (ATR)
- SBFM 0.08
- AQMS 0.09
- MACD
- SBFM 0.00
- AQMS 0.01
- Stochastic Oscillator
- SBFM 78.48
- AQMS 8.30
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.